计算工具,以协助分析SERPINA1基因变异对α-1抗素 (AAT) 的影响
Jakub Mróz1, Magdalena Pelc2, Karolina Mitusińska1
1Tunneling Group, Biotechnology Center, Silesian University of Technology, Krzywoustego St. 8, 44-100 Gliwice, Poland.
Genes
|March 28, 2024
概括
生物信息工具预测SERPINA1基因中的单核酸变体 (SNV),有助于理解α-1抗素缺乏症 (AATD). 这引导了个性化医疗,并改善了患者的治疗结果.
科学领域:
- 生物信息学和计算生物学
- 遗传学和基因组学 遗传学和基因组学
- 分子医学是分子医学.
背景情况:
- 单核酸变体 (SNVs) 影响基因功能和疾病机制.
- 阿尔法-1抗素缺乏症 (AATD) 是一种与SERPINA1基因突变相关的遗传疾病.
- 了解SNV的影响对于个性化医学至关重要.
研究的目的:
- 为临床医生提供一本针对新型遗传变异的计算分析指南.
- 探索生物信息学方法来评估SERPINA1变异及其对α-1抗素 (AAT) 蛋白的影响.
- 为了提高对SERPINA1变异的临床意义的预测.
主要方法:
- 计算工具的应用用于SNV效应预测.
- 对SERPINA1基因和AAT蛋白的生物信息分析.
- 整合各种计算方法.
主要成果:
- 计算方法可以阐明SNVs引起的疾病的分子机制.
- 生物信息分析提供了关于SERPINA1变异对AAT结构和功能的影响的见解.
- 预测模型有助于理解遗传变异的临床意义.
结论:
- 生物信息工具对于理解像SERPINA1.1中那些遗传变异是必不可少的.
- 预测SNVs的影响有助于为AATD量身定制的治疗策略.
- 这种方法支持个性化医疗,改善患者的生活质量.
相关概念视频
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...


